{"acute kidney injury": 2.39, "addison's disease": 14.25, "adrenal disorder": 26.72, "adrenal insufficiency": 97.28, "adrenocortical insufficiency acute": 29.91, "adrenocorticotropic hormone deficiency": 225.79, "alanine aminotransferase increased": 2.6, "altered state of consciousness": 2.56, "amylase increased": 6.26, "aspartate aminotransferase increased": 2.85, "atrioventricular block complete": 2.6, "autoimmune colitis": 70.55, "autoimmune haemolytic anaemia": 4.36, "autoimmune hepatitis": 26.58, "autoimmune pancreatitis": 31.85, "autoimmune thyroiditis": 9.16, "blood corticotrophin decreased": 77.51, "blood creatine phosphokinase increased": 3.1, "blood lactate dehydrogenase increased": 2.08, "blood thyroid stimulating hormone abnormal": 19.98, "blood thyroid stimulating hormone decreased": 10.86, "blood thyroid stimulating hormone increased": 3.52, "brain oedema": 2.5, "bronchopulmonary aspergillosis": 2.28, "c-reactive protein increased": 3.11, "central hypothyroidism": 8.92, "cholangitis": 9.46, "cholangitis sclerosing": 18.59, "cholecystitis": 3.26, "cholestasis": 4.58, "chronic gastritis": 4.11, "colitis": 42.04, "colitis microscopic": 4.65, "coronavirus infection": 2.82, "cortisol decreased": 25.91, "cytokine release syndrome": 8.22, "cytomegalovirus enterocolitis": 11.42, "decreased appetite": 2.51, "dermatitis": 4.55, "dermatitis bullous": 2.12, "dermatitis exfoliative generalised": 2.61, "dermatitis psoriasiform": 6.01, "diabetes mellitus": 2.07, "diabetic ketoacidosis": 3.17, "disseminated intravascular coagulation": 7.38, "drug eruption": 8.36, "drug-induced liver injury": 6.98, "duodenitis": 10.35, "dyslalia": 7.9, "encephalitis": 10.6, "encephalitis autoimmune": 11.44, "endocrine disorder": 23.44, "enteritis": 7.26, "enterocolitis": 29.7, "eosinophil count increased": 6.91, "eosinophilia": 3.72, "erythema multiforme": 10.73, "eyelid ptosis": 6.08, "febrile neutropenia": 2.42, "fulminant type 1 diabetes mellitus": 123.47, "gastritis": 2.61, "gastrointestinal perforation": 3.14, "general physical health deterioration": 2.14, "glucocorticoid deficiency": 25.14, "graves' disease": 2.98, "guillain-barre syndrome": 2.72, "haemophagocytic lymphohistiocytosis": 15.9, "hair colour changes": 2.48, "hepatic cytolysis": 7.72, "hepatic failure": 2.35, "hepatic function abnormal": 13.46, "hepatitis": 15.74, "hepatitis acute": 4.8, "hepatitis cholestatic": 2.38, "hepatitis fulminant": 8.15, "hepatocellular injury": 2.51, "hepatotoxicity": 4.81, "hiccups": 2.46, "hypercalcaemia": 3.56, "hyperlipasaemia": 12.89, "hyperthyroidism": 24.85, "hypertransaminasaemia": 2.57, "hypoalbuminaemia": 2.05, "hyponatraemia": 4.6, "hypophysitis": 115.65, "hypopituitarism": 178.38, "hypothalamo-pituitary disorder": 69.78, "hypothyroidism": 22.25, "ileus": 2.19, "immune thrombocytopenia": 2.53, "immune-mediated adrenal insufficiency": 152.26, "immune-mediated adverse reaction": 80.86, "immune-mediated arthritis": 62.64, "immune-mediated cholangitis": 38.86, "immune-mediated dermatitis": 218.17, "immune-mediated encephalitis": 46.91, "immune-mediated endocrinopathy": 85.39, "immune-mediated enterocolitis": 99.22, "immune-mediated gastritis": 49.88, "immune-mediated hepatic disorder": 146.33, "immune-mediated hepatitis": 61.97, "immune-mediated hyperthyroidism": 35.31, "immune-mediated hypophysitis": 90.99, "immune-mediated hypothyroidism": 36.54, "immune-mediated lung disease": 84.48, "immune-mediated myasthenia gravis": 27.37, "immune-mediated myocarditis": 40.58, "immune-mediated myositis": 44.94, "immune-mediated nephritis": 68.17, "immune-mediated pancreatitis": 76.09, "immune-mediated renal disorder": 63.21, "immune-mediated thyroiditis": 60.4, "immune-mediated uveitis": 38.51, "inappropriate antidiuretic hormone secretion": 2.3, "infectious pleural effusion": 7.46, "infusion related reaction": 4.33, "intentional product use issue": 23.44, "interstitial lung disease": 15.32, "intestinal perforation": 3.63, "large intestine perforation": 4.07, "leukoderma": 216.34, "lichenoid keratosis": 6.55, "lipase increased": 3.21, "liver disorder": 15.52, "lung disorder": 2.26, "lung opacity": 4.88, "lymphangiosis carcinomatosa": 8.58, "lymphocytic hypophysitis": 81.78, "malignant neoplasm progression": 20.51, "malignant pleural effusion": 6.33, "meningitis": 5.45, "meningitis aseptic": 10.43, "metastases to bone": 3.39, "metastases to central nervous system": 10.39, "metastases to liver": 2.76, "metastases to lung": 3.8, "metastases to lymph nodes": 4.44, "metastases to meninges": 4.5, "metastases to spine": 4.8, "metastatic malignant melanoma": 4.36, "myasthenia gravis": 17.79, "myasthenic syndrome": 10.97, "myocarditis": 4.38, "myositis": 22.91, "nephritis": 13.29, "neuropathy peripheral": 2.84, "neutrophil count decreased": 3.38, "non-small cell lung cancer": 297.87, "oesophagitis": 3.31, "organising pneumonia": 11.16, "pancreatic enzymes increased": 7.88, "pemphigoid": 3.93, "performance status decreased": 2.59, "peripheral sensory neuropathy": 4.13, "peritonitis": 2.45, "physical deconditioning": 3.49, "pituitary enlargement": 102.53, "pleural effusion": 2.72, "pneumocystis jirovecii pneumonia": 2.97, "pneumonia aspiration": 3.89, "pneumonia bacterial": 6.45, "pneumonitis": 19.21, "polyarthritis": 3.04, "polymyalgia rheumatica": 5.18, "polymyositis": 8.6, "prescribed overdose": 6.24, "prescribed underdose": 4.29, "primary adrenal insufficiency": 34.21, "pulmonary toxicity": 21.31, "radiation pneumonitis": 23.83, "rash": 2.81, "rash maculo-papular": 4.55, "renal disorder": 3.48, "renal impairment": 2.53, "rhabdomyolysis": 2.71, "sarcoidosis": 3.83, "secondary adrenocortical insufficiency": 205.94, "shock": 2.59, "sialoadenitis": 10.43, "silent thyroiditis": 140.02, "sjogren's syndrome": 3.82, "skin disorder": 6.77, "skin toxicity": 4.4, "stevens-johnson syndrome": 4.56, "thrombophlebitis migrans": 30.12, "thyroid disorder": 16.69, "thyroiditis": 60.85, "thyrotoxic crisis": 18.42, "toxic epidermal necrolysis": 5.67, "toxic skin eruption": 3.12, "troponin increased": 2.19, "tubulointerstitial nephritis": 14.42, "tumour haemorrhage": 6.31, "tumour lysis syndrome": 3.33, "tumour pseudoprogression": 44.05, "type 1 diabetes mellitus": 20.81, "uveitis": 6.75, "vitiligo": 9.68, "vogt-koyanagi-harada disease": 31.78}